Tech Stocks to Watch: 12 Picks from Wall Street Experts
Investing in technology stocks can be a lucrative opportunity for retail investors, but with so many options out there, it can be overwhelming to determine which ones are worth your attention. Luckily, Wall Street analysts have done some of the legwork for us and have identified 12 new technology stocks with promising potential.
First on the list is Everbridge Inc. (EVBG), a software company specializing in critical event management. The company's stock has gained over 140% in the past year, and ...
Read More About This
Read More About This
“Profit from Pharma: Top Dividend Stocks for 2025”
The pharmaceutical industry has always been a hot spot for investors, and it's no surprise that dividend stocks in this sector are highly sought after. With the constant demand for new drugs and treatments, pharmaceutical companies tend to have stable earnings and strong cash flows, making them attractive for those seeking consistent returns.
But with so many options out there, which pharma stocks should you consider for your portfolio? We've narrowed it down to the top 14 dividend stocks that are ...
Read More About This
Read More About This
Intuitive Machines (LUNR) Soars on Aggressive Expansion Plans
Intuitive Machines (LUNR) has seen a significant jump in its stock price for the fourth consecutive day, with shares rising by over 10%. This surge in value can be attributed to the company's recent announcement of aggressive expansion plans that have caught the attention of investors and traders alike.
The Houston-based aerospace and technology company revealed its plans to ramp up production of its innovative lunar lander, Nova-C, which is designed to transport payloads to the moon. This move comes after ...
Read More About This
Read More About This
“Oracle’s Rising CapEx: A Sign of Accelerating Revenue Growth?”
Oracle, one of the largest global technology companies, has been making headlines recently with its increased capital expenditures (CapEx). While some may view this as a concerning trend, one analyst believes it could actually lead to accelerated revenue growth for the company.
According to the analyst, Oracle's increased CapEx is a strategic move to invest in its cloud business and expand its infrastructure. This investment will not only help Oracle stay competitive with other cloud service providers, but also drive revenue ...
Read More About This
Read More About This
BofA Bullish on Amazon (AMZN) After Record-Breaking Prime Day
Amazon (AMZN) has once again proven its dominance in the retail world with a highly successful Prime Day event. The online retail giant's annual sales event, which took place on October 13 and 14, surpassed both Black Friday and Cyber Monday sales combined. This impressive performance has caught the attention of Bank of America (BofA), who has raised their price target for AMZN to a bullish $248.
BofA's bullish outlook on Amazon is largely based on the record-breaking Prime Day sales ...
Read More About This
Read More About This
“Why Wall Street is Bullish on GitLab (GTLB) Stock Thanks to AI Growth Potential”
GitLab (GTLB) stock has been making waves on Wall Street, and for good reason. The software company, known for its collaboration and DevOps tools, has been catching the attention of investors and analysts with its promising growth potential fueled by artificial intelligence (AI). So why is Wall Street so bullish on GTLB stock and what does this mean for retail investors?
First, let's break down what exactly makes GitLab's AI capabilities so exciting. The company has been heavily investing in AI ...
Read More About This
Read More About This
“Two Biotech Companies Team Up to Fight Colorectal Cancer”
Tempus AI, Inc. (TEM) and Personalis are joining forces to tackle one of the most common and deadly forms of cancer - colorectal cancer. This partnership brings together the cutting-edge technology of Tempus AI with Personalis' expertise in personalized medicine, creating a powerful combination that could potentially save lives and make a significant impact in the biotech industry.
Colorectal cancer affects millions of people worldwide, with over 1.8 million new cases diagnosed each year. Despite advancements in treatment, the survival rates ...
Read More About This
Read More About This
“Score Big with These 12 Undervalued Stocks Recommended by Experts”
Looking for some insider tips on the best stocks to invest in? Look no further than these 12 under-the-radar gems that are currently trading at their 52-week low. According to analysts, these companies have strong potential for growth and are currently undervalued in the market.
One of the most enticing aspects of these stocks is their low entry point, making them a prime opportunity for retail investors to get in on the action. With the market currently experiencing volatility, now is ...
Read More About This
Read More About This